Benzyl carbazateCAS# 5331-43-1 |
2D Structure
Quality Control & MSDS
3D structure
Package In Stock
Number of papers citing our products
Cas No. | 5331-43-1 | SDF | Download SDF |
PubChem ID | 79242 | Appearance | Powder |
Formula | C8H10N2O2 | M.Wt | 166 |
Type of Compound | N/A | Storage | Desiccate at -20°C |
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
Chemical Name | benzyl N-aminocarbamate | ||
SMILES | C1=CC=C(C=C1)COC(=O)NN | ||
Standard InChIKey | RXUBZLMIGSAPEJ-UHFFFAOYSA-N | ||
Standard InChI | InChI=1S/C8H10N2O2/c9-10-8(11)12-6-7-4-2-1-3-5-7/h1-5H,6,9H2,(H,10,11) | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Benzyl carbazate Dilution Calculator
Benzyl carbazate Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 6.0241 mL | 30.1205 mL | 60.241 mL | 120.4819 mL | 150.6024 mL |
5 mM | 1.2048 mL | 6.0241 mL | 12.0482 mL | 24.0964 mL | 30.1205 mL |
10 mM | 0.6024 mL | 3.012 mL | 6.0241 mL | 12.0482 mL | 15.0602 mL |
50 mM | 0.1205 mL | 0.6024 mL | 1.2048 mL | 2.4096 mL | 3.012 mL |
100 mM | 0.0602 mL | 0.3012 mL | 0.6024 mL | 1.2048 mL | 1.506 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- L-NMMA acetate
Catalog No.:BCC6788
CAS No.:53308-83-1
- 1,2,4-Benzenetriol
Catalog No.:BCC8409
CAS No.:533-73-3
- Sesamol
Catalog No.:BCN2594
CAS No.:533-31-3
- Tigloidine
Catalog No.:BCN1945
CAS No.:533-08-4
- Fmoc-Cys(Bzl)-OH
Catalog No.:BCC3475
CAS No.:53298-33-2
- CV 1808
Catalog No.:BCC7163
CAS No.:53296-10-9
- [Ala11,D-Leu15]-Orexin B
Catalog No.:BCC5877
CAS No.:532932-99-3
- Boc-Tyr(Me)-OH
Catalog No.:BCC3268
CAS No.:53267-93-9
- H-Sar-NH2.HCl
Catalog No.:BCC3333
CAS No.:5325-64-4
- 2''-O-Galloylhyperin
Catalog No.:BCN1218
CAS No.:53209-27-1
- Coixol
Catalog No.:BCN5703
CAS No.:532-91-2
- ar-Turmerone
Catalog No.:BCN7516
CAS No.:532-65-0
- Isogosferol
Catalog No.:BCN5704
CAS No.:53319-52-1
- PP 3
Catalog No.:BCC7486
CAS No.:5334-30-5
- Z-Leu-OH.DCHA
Catalog No.:BCC2765
CAS No.:53363-87-4
- Boc-N-Me-Leu-OH
Catalog No.:BCC2616
CAS No.:53363-89-6
- trans,trans-Bis(4-fluorobenzal)acetone
Catalog No.:BCC9180
CAS No.:53369-00-9
- 1,3,5-Trihydroxy-4-prenylxanthone
Catalog No.:BCN5705
CAS No.:53377-61-0
- Isovitexin 2'-O-arabinoside
Catalog No.:BCN7826
CAS No.:53382-71-1
- Erteberel (LY500307)
Catalog No.:BCC4491
CAS No.:533884-09-2
- 2-Aminodiphenylamine
Catalog No.:BCC8548
CAS No.:534-85-0
- D-Leu-ol
Catalog No.:BCC2583
CAS No.:53448-09-2
- 2-Aminonicotinic acid
Catalog No.:BCC8552
CAS No.:5345-47-1
- Vaccarin
Catalog No.:BCN2277
CAS No.:53452-16-7
New cobalt(II) and nickel(II) complexes of benzyl carbazate Schiff bases: Syntheses, crystal structures, in vitro DNA and HSA binding studies.[Pubmed:27816644]
J Photochem Photobiol B. 2016 Dec;165:220-231.
In the present study, new Schiff base complexes with the composition [M(NCS)2(L1)2].nH2O, where M=Co (n=0) (1) and Ni (n=2) (2); [M(NCS)2(L2)2], M=Co (3) and Ni (4) as well as [M(NCS)2(L3)2], M=Co (5) and Ni (6); (L1=benzyl 2-(propan-2-ylidene)hydrazinecarboxylate, L2=benzyl 2-(butan-2-ylidene)hydrazinecarboxylate and L3=benzyl 2-(pentan-3-ylidene)hydrazinecarboxylate) have been synthesized by a template method. The complexes were characterised by analytical methods, spectroscopic studies, thermal and X-ray diffraction techniques. The structures of all the complexes explore that the metal(II) cation has a trans-planar coordination environment, the monomeric units containing a six-coordinated metal center in octahedral geometry with N-bound isothiocyanate anions coordinated as terminal ligands. Furthermore, the binding of the two Schiff base ligands to the metal centers involves the azomethine nitrogen and the carbonyl oxygen in mutually trans configuration. The binding interactions of all the complexes with Calf thymus-deoxyribonucleic acid (CT-DNA) and human serum albumin (HSA) have been investigated using absorption and emission spectral techniques. The CT-DNA binding properties of these complexes reveal that they bind to CT-DNA through a partial intercalation mode and the binding constant values were calculated using the absorption and emission spectral data. The binding constant values (~10x10(6)moldm(-3)) indicate strong binding of metal complexes with CT-DNA. HSA binding interaction studies showed that the cobalt and nickel complexes can quench the intrinsic fluorescence of HSA through static quenching process. Also, molecular docking studies were supported out to apprehend the binding interactions of these complexes with DNA and HSA which offer new understandings into the experimental model observations.
Intramolecular Alkene Aminocarbonylation Using Concerted Cycloadditions of Amino-Isocyanates.[Pubmed:27112602]
Chemistry. 2016 Jun 1;22(23):7906-16.
The ubiquity of nitrogen heterocycles in biologically active molecules challenges synthetic chemists to develop a variety of tools for their construction. While developing metal-free hydroamination reactions of hydrazine derivatives, it was discovered that carbazates and semicarbazides can also lead to alkene aminocarbonylation products if nitrogen-substituted isocyanates (N-isocyanates) are formed in situ as reactive intermediates. At first this reaction required high temperatures (150-200 degrees C), and issues included competing hydroamination and N-isocyanate dimerization pathways. Herein, improved conditions for concerted intramolecular alkene aminocarbonylation with N-isocyanates are reported. The use of betaN-Benzyl carbazate precursors allows the effective minimization of N-isocyanate dimerization. Diminished dimerization leads to higher yields of alkene aminocarbonylation products, to reactivity at lower temperatures, and to an improved scope for a reaction sequence involving alkene aminocarbonylation followed by 1,2-migration of the benzyl group. Furthermore, fine-tuning of the blocking (masking) group on the N-isocyanate precursor, and reaction conditions relying on base catalysis for N-isocyanate formation from simpler precursors resulted in room temperature reactivity, consequently minimizing the competing hydroamination pathway. Collectively, this work highlights that controlled reactivity of aminoisocyanates is possible, and provides a broadly applicable alkene aminocarbonylation approach to heterocycles possessing the beta-aminocarbonyl motif.